[S02DA03, antipyrine, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Antipyrine.]
[B01AD01, streptokinase, The risk or severity of adverse effects can be increased when Streptokinase is combined with Doxazosin.]
[J01EC02, sulfadiazine, The metabolism of Doxazosin can be decreased when combined with Sulfadiazine.]
[S01AB01, sulfamethizole, The metabolism of Doxazosin can be decreased when combined with Sulfamethizole.]
[J01EC01, sulfamethoxazole, The metabolism of Doxazosin can be decreased when combined with Sulfamethoxazole.]
[J01EC03, sulfamoxole, The metabolism of Doxazosin can be decreased when combined with Sulfamoxole.]
[J01EB04, sulfapyridine, The metabolism of Doxazosin can be decreased when combined with Sulfapyridine.]
[M04AB02, sulfinpyrazone, The metabolism of Doxazosin can be decreased when combined with Sulfinpyrazone.]
[S01AB02, sulfisoxazole, The metabolism of Doxazosin can be decreased when combined with Sulfisoxazole.]
[M01AB02, sulindac, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Sulindac.]
[A10BB04, glibornuride, The metabolism of Glibornuride can be decreased when combined with Doxazosin.]
[M01AX04, apazone, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Azapropazone.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Doxazosin.]
[L01CB02, teniposide, The metabolism of Teniposide can be decreased when combined with Doxazosin.]
[R03CC03, terbutaline, The therapeutic efficacy of Terbutaline can be decreased when used in combination with Doxazosin.]
[G03BA03, testosterone, The metabolism of Doxazosin can be increased when combined with Testosterone.]
[N07XX06, tetrabenazine, The metabolism of Tetrabenazine can be decreased when combined with Doxazosin.]
[S03AA02, tetracycline, The metabolism of Doxazosin can be decreased when combined with Tetracycline.]
[N05AE05, lurasidone, Doxazosin may increase the hypotensive activities of Lurasidone.]
[A04AD10, dronabinol, The metabolism of Doxazosin can be decreased when combined with Dronabinol.]
[N04BC07, apomorphine, The risk or severity of adverse effects can be increased when Doxazosin is combined with Apomorphine.]
[L04AX02, thalidomide, The risk or severity of adverse effects can be increased when Doxazosin is combined with Thalidomide.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Doxazosin.]
[A11DA01, thiamine, The risk or severity of adverse effects can be increased when Doxazosin is combined with Thiamine.]
[L01AC01, thiotepa, The metabolism of Thiotepa can be decreased when combined with Doxazosin.]
[N05CA19, thiopental, Thiopental may increase the hypotensive activities of Doxazosin.]
[N05AB08, thioproperazine, Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Thioproperazine.]
[N05AC02, thioridazine, Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Thioridazine.]
[C01BB04, aprindine, The metabolism of Aprindine can be decreased when combined with Doxazosin.]
[G04BE06, moxisylyte, Moxisylyte may decrease the antihypertensive activities of Doxazosin.]
[B01AC05, ticlopidine, The metabolism of Doxazosin can be decreased when combined with Ticlopidine.]
[S01ED01, timolol, Timolol may increase the orthostatic hypotensive activities of Doxazosin.]
[A10BB05, tolazamide, The metabolism of Tolazamide can be decreased when combined with Doxazosin.]
[M02AX02, tolazoline, Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Tolazoline.]
[V04CA01, tolbutamide, The metabolism of Tolbutamide can be decreased when combined with Doxazosin.]
[M02AA21, tolmetin, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Tolmetin.]
[N02AX02, tramadol, The metabolism of Doxazosin can be decreased when combined with Tramadol.]
[N06AF04, tranylcypromine, The metabolism of Doxazosin can be decreased when combined with Tranylcypromine.]
[N06AX05, trazodone, Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Trazodone.]
[L01XF01, tretinoin, The risk or severity of adverse effects can be increased when Doxazosin is combined with Tretinoin.]
[S01BA05, triamcinolone, The metabolism of Doxazosin can be increased when combined with Triamcinolone.]
[C03DB02, triamterene, The risk or severity of adverse effects can be increased when Triamterene is combined with Doxazosin.]
[C03AA06, trichlormethiazide, The therapeutic efficacy of Doxazosin can be increased when used in combination with Trichlormethiazide.]
[N05AB06, trifluoperazine, Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Trifluoperazine.]
[R03BA07, mometasone, The metabolism of Doxazosin can be increased when combined with Mometasone.]
[A03AA05, trimebutine, The risk or severity of hypotension can be increased when Doxazosin is combined with Trimebutine.]
[S01ED04, metipranolol, Doxazosin may increase the hypotensive activities of Metipranolol.]
[N03AC02, trimethadione, The risk or severity of hypotension can be increased when Doxazosin is combined with Trimethadione.]
[C02BA01, trimethaphan, Doxazosin may increase the hypotensive activities of Trimethaphan.]
[J01EA01, trimethoprim, The metabolism of Doxazosin can be decreased when combined with Trimethoprim.]
[N06AA06, trimipramine, Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Trimipramine.]
[R06AC04, tripelennamine, The metabolism of Doxazosin can be decreased when combined with Tripelennamine.]
[J01FA08, troleandomycin, The metabolism of Doxazosin can be decreased when combined with Troleandomycin.]
[N06AX24, vilazodone, The metabolism of Doxazosin can be decreased when combined with Vilazodone.]
[C09CA09, azilsartan medoxomil, Doxazosin may increase the hypotensive activities of Azilsartan medoxomil.]
[M03AA02, tubocurarine, The risk or severity of adverse effects can be increased when Doxazosin is combined with Tubocurarine.]
[R03DX07, roflumilast, The metabolism of Roflumilast can be decreased when combined with Doxazosin.]
[L01EX04, vandetanib, The metabolism of Vandetanib can be decreased when combined with Doxazosin.]
[L02BX03, abiraterone, The metabolism of Doxazosin can be decreased when combined with Abiraterone.]
[A10BH05, linagliptin, The metabolism of Doxazosin can be decreased when combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Doxazosin can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Doxazosin can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, The metabolism of Doxazosin can be decreased when combined with Rilpivirine.]
[R03AC18, indacaterol, The therapeutic efficacy of Indacaterol can be decreased when used in combination with Doxazosin.]
[B01AC24, ticagrelor, The metabolism of Doxazosin can be decreased when combined with Ticagrelor.]
[C08DA01, verapamil, Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Verapamil.]
[N06AX09, viloxazine, The metabolism of Doxazosin can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The metabolism of Vinblastine can be decreased when combined with Doxazosin.]
[C04AX07, vincamine, Doxazosin may increase the hypotensive activities of Vincamine.]
[L01CA02, vincristine, The metabolism of Vincristine can be decreased when combined with Doxazosin.]
[L01CA03, vindesine, The metabolism of Vindesine can be decreased when combined with Doxazosin.]
[A11HA03, vitamin E, The metabolism of Doxazosin can be increased when combined with Vitamin E.]
[B01AA03, warfarin, The metabolism of Warfarin can be decreased when combined with Doxazosin.]
[S01AA13, fusidic acid, The metabolism of Doxazosin can be decreased when combined with Fusidic acid.]
[N01AX15, xenon, Xenon may decrease the antihypertensive activities of Doxazosin.]
[C03BA10, xipamide, Doxazosin may increase the hypotensive activities of Xipamide.]
[J05AF01, zidovudine, The metabolism of Doxazosin can be decreased when combined with Zidovudine.]
[N05AF05, zuclopenthixol, Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Zuclopenthixol.]
[J05AE02, indinavir, The metabolism of Doxazosin can be decreased when combined with Indinavir.]
[L01EC01, vemurafenib, The metabolism of Vemurafenib can be decreased when combined with Doxazosin.]
[L01FX05, brentuximab vedotin, The metabolism of Brentuximab vedotin can be decreased when combined with Doxazosin.]
[L01ED01, crizotinib, The metabolism of Crizotinib can be decreased when combined with Doxazosin.]
[R03DC01, zafirlukast, The metabolism of Doxazosin can be decreased when combined with Zafirlukast.]
[A02BC04, rabeprazole, The metabolism of Doxazosin can be decreased when combined with Rabeprazole.]
[N05AE04, ziprasidone, Ziprasidone may increase the antihypertensive activities of Doxazosin.]
[G03AC10, drospirenone, The metabolism of Drospirenone can be decreased when combined with Doxazosin.]
[N02BA01, aspirin, Acetylsalicylic acid may decrease the antihypertensive activities of Doxazosin.]
[L01EJ01, ruxolitinib, The metabolism of Ruxolitinib can be decreased when combined with Doxazosin.]
[G04BD07, tolterodine, The metabolism of Tolterodine can be decreased when combined with Doxazosin.]
[C07AB03, atenolol, Atenolol may increase the orthostatic hypotensive activities of Doxazosin.]
[L01FA01, rituximab, Doxazosin may increase the hypotensive activities of Rituximab.]
[J02AC03, voriconazole, The metabolism of Doxazosin can be decreased when combined with Voriconazole.]
[S01FA01, atropine, Atropine may decrease the antihypertensive activities of Doxazosin.]
[L01XJ01, vismodegib, The metabolism of Vismodegib can be decreased when combined with Doxazosin.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Doxazosin.]
[R07AX02, ivacaftor, The metabolism of Doxazosin can be decreased when combined with Ivacaftor.]
[H02AB11, prednylidene, The metabolism of Doxazosin can be increased when combined with Prednylidene.]
[G04BE10, avanafil, The risk or severity of hypotension can be increased when Avanafil is combined with Doxazosin.]
[M03BX01, baclofen, The risk or severity of adverse effects can be increased when Baclofen is combined with Doxazosin.]
[A08AA11, lorcaserin, The metabolism of Doxazosin can be decreased when combined with Lorcaserin.]
[G04BD12, mirabegron, The serum concentration of Doxazosin can be increased when it is combined with Mirabegron.]
[V03AX03, cobicistat, The metabolism of Doxazosin can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Doxazosin can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Doxazosin can be decreased when it is combined with Enzalutamide.]
[L01EA04, bosutinib, The metabolism of Bosutinib can be decreased when combined with Doxazosin.]
[C01CA18, octopamine, The therapeutic efficacy of Octopamine can be decreased when used in combination with Doxazosin.]
[L01EX05, regorafenib, The metabolism of Regorafenib can be decreased when combined with Doxazosin.]
[N05CA04, barbital, Barbital may increase the hypotensive activities of Doxazosin.]
[J05AE04, nelfinavir, The metabolism of Doxazosin can be decreased when combined with Nelfinavir.]
[S01GA07, brimonidine, Brimonidine may increase the antihypertensive activities of Doxazosin.]
[N04BD02, rasagiline, Rasagiline may increase the hypotensive activities of Doxazosin.]
[C08CA13, lercanidipine, The risk or severity of hypotension can be increased when Doxazosin is combined with Lercanidipine.]
[N06DA02, donepezil, The metabolism of Donepezil can be decreased when combined with Doxazosin.]
[N03AX22, perampanel, The metabolism of Doxazosin can be increased when combined with Perampanel.]
[N02CC03, zolmitriptan, Zolmitriptan may decrease the antihypertensive activities of Doxazosin.]
[G04BD10, darifenacin, The metabolism of Doxazosin can be decreased when combined with Darifenacin.]
[N01AA01, ethyl ether, Diethyl ether may decrease the antihypertensive activities of Doxazosin.]
[L01EX07, cabozantinib, The metabolism of Cabozantinib can be decreased when combined with Doxazosin.]
[H01CB05, pasireotide, The metabolism of Doxazosin can be decreased when combined with Pasireotide.]
[G04BE03, sildenafil, The risk or severity of hypotension can be increased when Sildenafil is combined with Doxazosin.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Doxazosin.]
[B01AF02, apixaban, The metabolism of Apixaban can be decreased when combined with Doxazosin.]
[C10AX12, lomitapide, The metabolism of Lomitapide can be decreased when combined with Doxazosin.]
[C04AX11, bencyclane, The risk or severity of hypotension can be increased when Doxazosin is combined with Bencyclane.]
[A10BH04, alogliptin, The metabolism of Alogliptin can be decreased when combined with Doxazosin.]
[A16AX09, glycerol phenylbutyrate, The metabolism of Doxazosin can be decreased when combined with Glycerol phenylbutyrate.]
[C03AA01, bendroflumethiazide, The therapeutic efficacy of Doxazosin can be increased when used in combination with Bendroflumethiazide.]
[L04AX06, pomalidomide, The metabolism of Pomalidomide can be decreased when combined with Doxazosin.]
[G03XC05, ospemifene, The metabolism of Doxazosin can be decreased when combined with Ospemifene.]
[N02BA10, benorilate, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Benorilate.]
[A10BK02, canagliflozin, The risk or severity of adverse effects can be increased when Doxazosin is combined with Canagliflozin.]
[M04AB03, benzbromarone, The metabolism of Doxazosin can be decreased when combined with Benzbromarone.]
[A06AX06, tegaserod, The metabolism of Doxazosin can be decreased when combined with Tegaserod.]
[R02AD01, benzocaine, The metabolism of Benzocaine can be decreased when combined with Doxazosin.]
[M01AH01, celecoxib, The metabolism of Doxazosin can be decreased when combined with Celecoxib.]
[N02CC02, naratriptan, Naratriptan may decrease the antihypertensive activities of Doxazosin.]
[L04AA18, everolimus, The metabolism of Everolimus can be decreased when combined with Doxazosin.]
[N04AC01, benztropine, The metabolism of Doxazosin can be decreased when combined with Benzatropine.]
[L01EC02, dabrafenib, The serum concentration of Doxazosin can be decreased when it is combined with Dabrafenib.]
[R02AX03, benzydamine, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Benzydamine.]
[P03AX06, benzyl alcohol, The metabolism of Benzyl alcohol can be decreased when combined with Doxazosin.]
[N06AX28, levomilnacipran, The metabolism of Levomilnacipran can be decreased when combined with Doxazosin.]
[C08EA02, bepridil, The risk or severity of hypotension can be increased when Doxazosin is combined with Bepridil.]
[C02KX05, riociguat, Doxazosin may increase the hypotensive activities of Riociguat.]
[C02KX04, macitentan, Doxazosin may increase the hypotensive activities of Macitentan.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Doxazosin.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be decreased when combined with Doxazosin.]
[N03AF04, eslicarbazepine, The metabolism of Doxazosin can be increased when combined with Eslicarbazepine.]
[D01AC18, luliconazole, The serum concentration of Doxazosin can be increased when it is combined with Luliconazole.]
[J05AP05, simeprevir, The metabolism of Doxazosin can be decreased when combined with Simeprevir.]
[A10BK01, dapagliflozin, The risk or severity of adverse effects can be increased when Doxazosin is combined with Dapagliflozin.]
[C01CA27, droxidopa, The therapeutic efficacy of Droxidopa can be decreased when used in combination with Doxazosin.]
[C07AB04, acebutolol, Acebutolol may increase the orthostatic hypotensive activities of Doxazosin.]
[N05CH03, tasimelteon, The metabolism of Tasimelteon can be decreased when combined with Doxazosin.]
[A16AA07, metreleptin, The metabolism of Doxazosin can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Doxazosin can be increased when combined with Apremilast.]
[L02BG02, formestane, The metabolism of Doxazosin can be increased when combined with Formestane.]
[S03BA03, betamethasone, The metabolism of Doxazosin can be increased when combined with Betamethasone.]
[S01ED02, betaxolol, Betaxolol may increase the orthostatic hypotensive activities of Doxazosin.]
[C02CC01, bethanidine, The therapeutic efficacy of Bethanidine can be decreased when used in combination with Doxazosin.]
[L04AC11, siltuximab, The metabolism of Doxazosin can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The metabolism of Ceritinib can be decreased when combined with Doxazosin.]
[B01AC26, vorapaxar, The metabolism of Vorapaxar can be decreased when combined with Doxazosin.]
[B01AA07, acenocoumarol, The metabolism of Acenocoumarol can be decreased when combined with Doxazosin.]
[L01EM01, idelalisib, The metabolism of Idelalisib can be decreased when combined with Doxazosin.]
[A10BK03, empagliflozin, The risk or severity of adverse effects can be increased when Doxazosin is combined with Empagliflozin.]
[R03AC19, olodaterol, The therapeutic efficacy of Olodaterol can be decreased when used in combination with Doxazosin.]
[S01EE02, unoprostone, Doxazosin may increase the hypotensive activities of Unoprostone.]
[N05CM19, suvorexant, The metabolism of Suvorexant can be decreased when combined with Doxazosin.]
[A16AX10, eliglustat, The metabolism of Doxazosin can be decreased when combined with Eliglustat.]
[J01XA05, oritavancin, The metabolism of Doxazosin can be increased when combined with Oritavancin.]
[N05AA04, acepromazine, Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Acepromazine.]
[N04AA02, biperiden, The metabolism of Doxazosin can be decreased when combined with Biperiden.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be decreased when combined with Doxazosin.]
[L01EX09, nintedanib, The metabolism of Nintedanib can be decreased when combined with Doxazosin.]
[J05AP09, dasabuvir, The metabolism of Dasabuvir can be decreased when combined with Doxazosin.]
[L01XK01, olaparib, The metabolism of Olaparib can be decreased when combined with Doxazosin.]
[B01AA01, dicumarol, The metabolism of Doxazosin can be decreased when combined with Dicoumarol.]
[N06AX11, mirtazapine, Mirtazapine may decrease the antihypertensive activities of Doxazosin.]
[L04AC10, secukinumab, The metabolism of Doxazosin can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The metabolism of Palbociclib can be decreased when combined with Doxazosin.]
[L01XH03, panobinostat, The metabolism of Doxazosin can be decreased when combined with Panobinostat.]
[N02BE01, acetaminophen, The metabolism of Doxazosin can be increased when combined with Acetaminophen.]
[J05AP06, asunaprevir, The metabolism of Doxazosin can be decreased when combined with Asunaprevir.]
[N05AX16, brexpiprazole, Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Brexpiprazole.]
[L01XJ02, sonidegib, The metabolism of Sonidegib can be decreased when combined with Doxazosin.]
[A04AD14, rolapitant, The metabolism of Doxazosin can be decreased when combined with Rolapitant.]
[G02CX02, flibanserin, Flibanserin may decrease the antihypertensive activities of Doxazosin.]
[N05AX15, cariprazine, Cariprazine may decrease the antihypertensive activities of Doxazosin.]
[M02AA25, aceclofenac, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Aceclofenac.]
[M01AB11, acemetacin, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Acemetacin.]
[S01EC01, acetazolamide, The metabolism of Doxazosin can be decreased when combined with Acetazolamide.]
[A02BC03, lansoprazole, The metabolism of Doxazosin can be decreased when combined with Lansoprazole.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Doxazosin.]
[J02AC05, isavuconazole, The metabolism of Doxazosin can be decreased when combined with Isavuconazole.]
[L01EB04, osimertinib, The metabolism of Osimertinib can be decreased when combined with Doxazosin.]
[J05AF13, tenofovir alafenamide, The metabolism of Tenofovir alafenamide can be decreased when combined with Doxazosin.]
[L01EE02, cobimetinib, The metabolism of Cobimetinib can be decreased when combined with Doxazosin.]
[L01XG03, ixazomib, The metabolism of Ixazomib can be decreased when combined with Doxazosin.]
[L01ED03, alectinib, The metabolism of Alectinib can be decreased when combined with Doxazosin.]
[B01AC27, selexipag, Doxazosin may increase the hypotensive activities of Selexipag.]
[A10BB31, acetohexamide, The metabolism of Doxazosin can be decreased when combined with Acetohexamide.]
[G04CA01, alfuzosin, Doxazosin may increase the hypotensive activities of Alfuzosin.]
[M04AB05, lesinurad, The metabolism of Doxazosin can be increased when combined with Lesinurad.]
[N05CA05, aprobarbital, The metabolism of Doxazosin can be increased when combined with Aprobarbital.]
[M01AE16, alminoprofen, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Alminoprofen.]
[N03AX23, brivaracetam, The metabolism of Brivaracetam can be decreased when combined with Doxazosin.]
[L01XX52, venetoclax, The metabolism of Venetoclax can be decreased when combined with Doxazosin.]
[N04BC01, bromocriptine, Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Bromocriptine.]
[N06AA19, amineptin, Amineptine may decrease the antihypertensive activities of Doxazosin.]
[C08CA01, amlodipine, The risk or severity of hypotension can be increased when Doxazosin is combined with Amlodipine.]
[N05AX17, pimavanserin, The metabolism of Pimavanserin can be decreased when combined with Doxazosin.]
[C03CA02, bumetanide, The risk or severity of adverse effects can be increased when Doxazosin is combined with Bumetanide.]
[N01BB01, bupivacaine, The risk or severity of adverse effects can be increased when Bupivacaine is combined with Doxazosin.]
[C07AA19, bupranolol, Bupranolol may increase the orthostatic hypotensive activities of Doxazosin.]
[N07BC01, buprenorphine, The metabolism of Doxazosin can be decreased when combined with Buprenorphine.]
[N05BE01, buspirone, Buspirone may decrease the antihypertensive activities of Doxazosin.]
[L01AB01, busulfan, The metabolism of Busulfan can be decreased when combined with Doxazosin.]
[L01XX27, arsenic trioxide, The risk or severity of adverse effects can be increased when Doxazosin is combined with Arsenic trioxide.]
[P01BE02, artemether, The metabolism of Artemether can be decreased when combined with Doxazosin.]
[M02AA03, clofezone, The metabolism of Doxazosin can be decreased when combined with Rabeprazole.]
[S01GX07, azelastine, The metabolism of Doxazosin can be decreased when combined with Azelastine.]
[L01XK03, rucaparib, The metabolism of Doxazosin can be decreased when combined with Rucaparib.]
[S01AA26, azithromycin, The metabolism of Doxazosin can be decreased when combined with Azithromycin.]
[L01EF02, ribociclib, The metabolism of Doxazosin can be decreased when combined with Ribociclib.]
[A07EC04, balsalazide, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Balsalazide.]
[R03CC12, bambuterol, The therapeutic efficacy of Bambuterol can be decreased when used in combination with Doxazosin.]
[N07XX16, deutetrabenazine, The metabolism of Deutetrabenazine can be decreased when combined with Doxazosin.]
[C09AA07, benazepril, Benazepril may increase the hypotensive activities of Doxazosin.]
[D05AX03, calcitriol, The metabolism of Doxazosin can be increased when combined with Calcitriol.]
[J01XX08, linezolid, Linezolid may increase the hypotensive activities of Doxazosin.]
[J05AE09, tipranavir, The metabolism of Doxazosin can be decreased when combined with Tipranavir.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be decreased when combined with Doxazosin.]
[L04AB02, infliximab, The metabolism of Doxazosin can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Doxazosin can be decreased when combined with Midostaurin.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be decreased when combined with Doxazosin.]
[N04BD03, safinamide, Safinamide may increase the hypotensive activities of Doxazosin.]
[L04AC14, sarilumab, The metabolism of Doxazosin can be increased when combined with Sarilumab.]
[J01MA23, delafloxacin, The metabolism of Doxazosin can be increased when combined with Delafloxacin.]
[D01AC10, bifonazole, The metabolism of Doxazosin can be decreased when combined with Bifonazole.]
[S01EB09, acetylcholine, The risk or severity of adverse effects can be increased when Doxazosin is combined with Acetylcholine.]
[L01BC06, capecitabine, The metabolism of Doxazosin can be decreased when combined with Capecitabine.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Doxazosin.]
[L01EH02, neratinib, The metabolism of Neratinib can be decreased when combined with Doxazosin.]
[L01EM02, copanlisib, The metabolism of Copanlisib can be decreased when combined with Doxazosin.]
[L01EF03, abemaciclib, The metabolism of Abemaciclib can be decreased when combined with Doxazosin.]
[C07AB07, bisoprolol, Bisoprolol may increase the orthostatic hypotensive activities of Doxazosin.]
[R03AC17, bitolterol, The therapeutic efficacy of Bitolterol can be decreased when used in combination with Doxazosin.]
[J05AG03, efavirenz, The metabolism of Doxazosin can be decreased when combined with Efavirenz.]
[C07AA17, bopindolol, Bopindolol may increase the orthostatic hypotensive activities of Doxazosin.]
[C01DX19, nesiritide, The risk or severity of adverse effects can be increased when Doxazosin is combined with Nesiritide.]
[R03BA02, budesonide, The metabolism of Doxazosin can be increased when combined with Budesonide.]
[C04AX20, buflomedil, Buflomedil may decrease the antihypertensive activities of Doxazosin.]
[M01AB07, bumadizone, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Bumadizone.]
[L01EL02, acalabrutinib, The metabolism of Acalabrutinib can be decreased when combined with Doxazosin.]
[J05AX18, letermovir, The metabolism of Doxazosin can be decreased when combined with Letermovir.]
[N06AA15, butriptyline, Butriptyline may decrease the antihypertensive activities of Doxazosin.]
[N01BX04, capsaicin, The metabolism of Doxazosin can be decreased when combined with Capsaicin.]
[C09AA01, captopril, Doxazosin may increase the hypotensive activities of Captopril.]
[L02BB05, apalutamide, The serum concentration of Doxazosin can be increased when it is combined with Apalutamide.]
[N03AF01, carbamazepine, The metabolism of Doxazosin can be increased when combined with Carbamazepine.]
[C07AG02, carvedilol, Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Carvedilol.]
[B02BX09, fostamatinib, The risk or severity of hypotension can be increased when Fostamatinib is combined with Doxazosin.]
[N03AX24, cannabidiol, The metabolism of Doxazosin can be decreased when combined with Cannabidiol.]
[B02BX08, avatrombopag, The metabolism of Doxazosin can be increased when combined with Avatrombopag.]
[L01EC03, encorafenib, The metabolism of Encorafenib can be decreased when combined with Doxazosin.]
[C07AB08, celiprolol, The therapeutic efficacy of Celiprolol can be decreased when used in combination with Doxazosin.]
[H01CC03, elagolix, The metabolism of Elagolix can be decreased when combined with Doxazosin.]
[L01XX62, ivosidenib, The metabolism of Doxazosin can be increased when combined with Ivosidenib.]
[P01BA07, tafenoquine, The metabolism of Tafenoquine can be decreased when combined with Doxazosin.]
[N03AX17, stiripentol, The metabolism of Doxazosin can be decreased when combined with Stiripentol.]
[J05AX24, tecovirimat, The metabolism of Doxazosin can be increased when combined with Tecovirimat.]
[L01EM04, duvelisib, The metabolism of Duvelisib can be decreased when combined with Doxazosin.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Doxazosin.]
[A10BB06, carbutamide, The metabolism of Carbutamide can be decreased when combined with Doxazosin.]
[M01AC05, lornoxicam, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Lornoxicam.]
[M03BA02, carisoprodol, The metabolism of Doxazosin can be decreased when combined with Carisoprodol.]
[R03BB08, revefenacin, The metabolism of Revefenacin can be decreased when combined with Doxazosin.]
[L01ED05, lorlatinib, The metabolism of Doxazosin can be increased when combined with Lorlatinib.]
[L04AA39, emapalumab, The metabolism of Doxazosin can be increased when combined with Emapalumab.]
[L01EX13, gilteritinib, The metabolism of Gilteritinib can be decreased when combined with Doxazosin.]
[C09AA08, cilazapril, Doxazosin may increase the hypotensive activities of Cilazapril.]
[B01AC23, cilostazol, The metabolism of Cilostazol can be decreased when combined with Doxazosin.]
[A03FA08, cinitapride, Cinitapride may decrease the antihypertensive activities of Doxazosin.]
[S01ED05, carteolol, Carteolol may increase the hypotensive activities of Doxazosin.]
[P02BX04, triclabendazole, The metabolism of Doxazosin can be decreased when combined with Triclabendazole.]
[N06AX27, esketamine, The metabolism of Doxazosin can be increased when combined with Esketamine.]
[L04AA42, siponimod, The metabolism of Siponimod can be decreased when combined with Doxazosin.]
[J01FA09, clarithromycin, The metabolism of Doxazosin can be decreased when combined with Clarithromycin.]
[N06BA14, solriamfetol, Solriamfetol may decrease the antihypertensive activities of Doxazosin.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be decreased when combined with Doxazosin.]
[N05BA09, clobazam, The metabolism of Doxazosin can be decreased when combined with Clobazam.]
[H02AB14, cloprednol, The metabolism of Doxazosin can be increased when combined with Cloprednol.]
[C09CA06, candesartan, Doxazosin may increase the hypotensive activities of Candesartan.]
[L04AB01, etanercept, The metabolism of Doxazosin can be increased when combined with Etanercept.]
[H02AB17, cortivazol, The metabolism of Doxazosin can be increased when combined with Cortivazol.]
[L01EM03, alpelisib, The serum concentration of Doxazosin can be decreased when it is combined with Alpelisib.]
[L01EX15, pexidartinib, The metabolism of Pexidartinib can be decreased when combined with Doxazosin.]
[C03BX03, cicletanine, Doxazosin may increase the hypotensive activities of Cicletanine.]
[L01EJ02, fedratinib, The metabolism of Fedratinib can be decreased when combined with Doxazosin.]
[L01EX14, entrectinib, The metabolism of Entrectinib can be decreased when combined with Doxazosin.]
[N07XX11, pitolisant, The serum concentration of Doxazosin can be decreased when it is combined with Pitolisant.]
[J04AK08, pretomanid, The metabolism of Pretomanid can be decreased when combined with Doxazosin.]
[J01XX12, lefamulin, The metabolism of Lefamulin can be decreased when combined with Doxazosin.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Doxazosin.]
[C03AA09, cyclothiazide, The therapeutic efficacy of Doxazosin can be increased when used in combination with Cyclothiazide.]
[G04BE04, yohimbine, Yohimbine may decrease the antihypertensive activities of Doxazosin.]
[J01DB01, cephalexin, The metabolism of Doxazosin can be decreased when combined with Cephalexin.]
[J01DB09, cephradine, The metabolism of Doxazosin can be increased when combined with Cefradine.]
[H02AB13, deflazacort, The metabolism of Doxazosin can be increased when combined with Deflazacort.]
[L01FD03, ado-trastuzumab emtansine, The metabolism of Trastuzumab emtansine can be decreased when combined with Doxazosin.]
[L01EL03, zanubrutinib, The metabolism of Zanubrutinib can be decreased when combined with Doxazosin.]
[G03AC09, desogestrel, The metabolism of Doxazosin can be decreased when combined with Desogestrel.]
[B06AX03, voxelotor, The metabolism of Voxelotor can be decreased when combined with Doxazosin.]
[N03AX25, cenobamate, The serum concentration of Doxazosin can be decreased when it is combined with Cenobamate.]
[A16AX16, givosiran, The serum concentration of Doxazosin can be increased when it is combined with Givosiran.]
[R06AB02, dexchlorpheniramine, The metabolism of Doxazosin can be decreased when combined with Dexchlorpheniramine.]
[L01EX18, avapritinib, The metabolism of Doxazosin can be decreased when combined with Avapritinib.]
[L01XX72, tazemetostat, The metabolism of Tazemetostat can be decreased when combined with Doxazosin.]
[M01AX21, diacetylrhein, The metabolism of Doxazosin can be decreased when combined with Diacerein.]
[J05AB16, remdesivir, The metabolism of Doxazosin can be decreased when combined with Remdesivir.]
[H02CA02, osilodrostat, The metabolism of Doxazosin can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Doxazosin can be decreased when combined with Amprenavir.]
[N02CC07, frovatriptan, Frovatriptan may decrease the antihypertensive activities of Doxazosin.]
[G04CB02, dutasteride, Dutasteride may decrease the antihypertensive activities of Doxazosin.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be decreased when combined with Doxazosin.]
[N02AA08, dihydrocodeine, The metabolism of Dihydrocodeine can be decreased when combined with Doxazosin.]
[N02CC06, eletriptan, Eletriptan may decrease the antihypertensive activities of Doxazosin.]
[M01AH02, rofecoxib, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Rofecoxib.]
[L01XF03, bexarotene, The metabolism of Doxazosin can be increased when combined with Bexarotene.]
[C08CA16, clevidipine, The risk or severity of hypotension can be increased when Doxazosin is combined with Clevidipine.]
[C01BD07, dronedarone, The metabolism of Doxazosin can be decreased when combined with Dronedarone.]
[J01FA13, dirithromycin, The metabolism of Doxazosin can be decreased when combined with Dirithromycin.]
[S03AA08, chloramphenicol, The metabolism of Doxazosin can be decreased when combined with Chloramphenicol.]
[C02AA06, methoserpidine, Doxazosin may increase the hypotensive activities of Methoserpidine.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Doxazosin.]
[N04BX04, opicapone, The risk or severity of adverse effects can be increased when Doxazosin is combined with Opicapone.]
[C01CA14, dopexamine, The therapeutic efficacy of Dopexamine can be decreased when used in combination with Doxazosin.]
[D07XB03, fluprednidene, The metabolism of Doxazosin can be increased when combined with Fluprednidene.]
[G04BD09, trospium, The metabolism of Doxazosin can be decreased when combined with Trospium.]
[M01AC04, droxicam, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Droxicam.]
[L01EX22, selpercatinib, Selpercatinib may decrease the antihypertensive activities of Doxazosin.]
[M02AA27, dexketoprofen, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Dexketoprofen.]
[C08CA17, levamlodipine, The risk or severity of hypotension can be increased when Doxazosin is combined with Levamlodipine.]
[R06AX22, ebastine, The metabolism of Ebastine can be decreased when combined with Doxazosin.]
[P01BB01, proguanil, The metabolism of Proguanil can be decreased when combined with Doxazosin.]
[L04AC19, satralizumab, The serum concentration of Doxazosin can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The metabolism of Oliceridine can be decreased when combined with Doxazosin.]
[P01BA01, chloroquine, The metabolism of Doxazosin can be decreased when combined with Chloroquine.]
[L01EX23, pralsetinib, The metabolism of Doxazosin can be increased when combined with Pralsetinib.]
[C03AA04, chlorothiazide, The therapeutic efficacy of Doxazosin can be increased when used in combination with Chlorothiazide.]
[R06AB04, chlorpheniramine, The metabolism of Doxazosin can be decreased when combined with Chlorpheniramine.]
[N05AA01, chlorpromazine, Chlorpromazine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Doxazosin.]
[A10BB02, chlorpropamide, The metabolism of Chlorpropamide can be decreased when combined with Doxazosin.]
[C03BA04, chlorthalidone, Chlorthalidone may increase the hypotensive activities of Doxazosin.]
[M03BB03, chlorzoxazone, The metabolism of Doxazosin can be decreased when combined with Chlorzoxazone.]
[A11CC05, cholecalciferol, The metabolism of Doxazosin can be decreased when combined with Cholecalciferol.]
[N02BA07, ethenzamide, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Ethenzamide.]
[N02BA03, choline salicylate, The risk or severity of adverse effects can be increased when Doxazosin is combined with Choline salicylate.]
[N06BX18, vinpocetine, The risk or severity of hypotension can be increased when Doxazosin is combined with Vinpocetine.]
[M01AB08, etodolac, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Etodolac.]
[M02AA06, etofenamate, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Etofenamate.]
[B06AC06, berotralstat, The metabolism of Doxazosin can be decreased when combined with Berotralstat.]
[A16AX20, lonafarnib, The metabolism of Doxazosin can be decreased when combined with Lonafarnib.]
[L01FX21, naxitamab, Naxitamab may decrease the antihypertensive activities of Doxazosin.]
[P03AX07, abametapir, The serum concentration of Doxazosin can be increased when it is combined with Abametapir.]
[C01DX22, vericiguat, The risk or severity of adverse effects can be increased when Doxazosin is combined with Vericiguat.]
[L01EX21, tepotinib, The metabolism of Doxazosin can be decreased when combined with Tepotinib.]
[N03AX10, felbamate, The metabolism of Doxazosin can be decreased when combined with Felbamate.]
[M01AE05, fenbufen, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Fenbufen.]
[C01CA19, fenoldopam, Doxazosin may increase the hypotensive activities of Fenoldopam.]
[N06BA08, fenozolone, Fenozolone may decrease the antihypertensive activities of Doxazosin.]
[G04CB01, finasteride, Finasteride may decrease the antihypertensive activities of Doxazosin.]
[R03BA03, flunisolide, The metabolism of Doxazosin can be increased when combined with Flunisolide.]
[S02BA08, fluocinolone acetonide, The metabolism of Doxazosin can be increased when combined with Fluocinolone acetonide.]
[R03CC15, formoterol, The therapeutic efficacy of Formoterol can be decreased when used in combination with Doxazosin.]
[N01AB05, trichloroethylene, Trichloroethylene may decrease the antihypertensive activities of Doxazosin.]
[L03AB10, peginterferon alfa-2b, The metabolism of Doxazosin can be decreased when combined with Peginterferon alfa-2b.]
[H04AA02, dasiglucagon, Doxazosin may increase the hypotensive activities of Dasiglucagon.]
[A02BA01, cimetidine, The metabolism of Doxazosin can be decreased when combined with Cimetidine.]
[N07CA02, cinnarizine, The risk or severity of hypotension can be increased when Doxazosin is combined with Cinnarizine.]
[L01XX73, sotorasib, The serum concentration of Doxazosin can be decreased when it is combined with Sotorasib.]
[L01EN03, infigratinib, The metabolism of Infigratinib can be decreased when combined with Doxazosin.]
[S03AA07, ciprofloxacin, The metabolism of Doxazosin can be decreased when combined with Ciprofloxacin.]
[N06AB04, citalopram, The metabolism of Doxazosin can be decreased when combined with Citalopram.]
[H01AC07, somapacitan, The metabolism of Doxazosin can be decreased when combined with Somapacitan.]
[P01CA03, fexinidazole, The metabolism of Doxazosin can be decreased when combined with Fexinidazole.]
[L01XX74, belzutifan, The metabolism of Belzutifan can be decreased when combined with Doxazosin.]
[L04AA59, avacopan, The metabolism of Doxazosin can be decreased when combined with Avacopan.]
[R06AA04, clemastine, The metabolism of Doxazosin can be decreased when combined with Clemastine.]
[A10BB12, glimepiride, The metabolism of Doxazosin can be decreased when combined with Glimepiride.]
[A10BB08, gliquidone, The metabolism of Gliquidone can be decreased when combined with Doxazosin.]
[R03CC13, clenbuterol, The therapeutic efficacy of Clenbuterol can be decreased when used in combination with Doxazosin.]
[N06AX25, St. John's wort extract, The metabolism of Doxazosin can be increased when combined with St. John's Wort.]
[L01EA06, asciminib, The metabolism of Doxazosin can be decreased when combined with Asciminib.]
[L03AB15, ropeginterferon alfa-2b, The metabolism of Doxazosin can be decreased when combined with Ropeginterferon alfa-2b.]
[D11AH08, abrocitinib, The metabolism of Abrocitinib can be decreased when combined with Doxazosin.]
[J04BA01, clofazimine, The metabolism of Doxazosin can be decreased when combined with Clofazimine.]
[C10AB01, clofibrate, The metabolism of Doxazosin can be increased when combined with Clofibrate.]
[B06AX04, mitapivat, The metabolism of Doxazosin can be increased when combined with Mitapivat.]
[N01BB10, levobupivacaine, The risk or severity of adverse effects can be increased when Doxazosin is combined with Levobupivacaine.]
[L01EJ03, pacritinib, The metabolism of Doxazosin can be decreased when combined with Pacritinib.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Doxazosin.]
[S01EA04, clonidine, The risk or severity of hypotension can be increased when Clonidine is combined with Doxazosin.]
[C01EB24, mavacamten, The serum concentration of Doxazosin can be decreased when it is combined with Mavacamten.]
[A02BC08, vonoprazan, The metabolism of Doxazosin can be decreased when combined with Vonoprazan.]
[A04AA01, ondansetron, The metabolism of Ondansetron can be decreased when combined with Doxazosin.]
[N05AH02, clozapine, Clozapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Doxazosin.]
[H01AC08, somatrogon, The metabolism of Doxazosin can be increased when combined with Somatrogon.]
[S02DA02, cocaine, The metabolism of Doxazosin can be decreased when combined with Cocaine.]
[C02KB01, metyrosine, Doxazosin may increase the hypotensive activities of Metyrosine.]
[L04AC21, bimekizumab, The metabolism of Doxazosin can be increased when combined with Bimekizumab.]
[M01AX13, proquazone, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Proquazone.]
[R05DA04, codeine, The risk or severity of adverse effects can be increased when Doxazosin is combined with Codeine.]
[L04AA13, leflunomide, The metabolism of Doxazosin can be decreased when combined with Leflunomide.]
[N01AB07, desflurane, Desflurane may decrease the antihypertensive activities of Doxazosin.]
[C04AX28, ifenprodil, Ifenprodil may decrease the antihypertensive activities of Doxazosin.]
[A10BX03, nateglinide, The metabolism of Nateglinide can be decreased when combined with Doxazosin.]
[N02BA16, imidazole-2-hydroxybenzoate, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Imidazole salicylate.]
[J01FA15, telithromycin, The metabolism of Doxazosin can be decreased when combined with Telithromycin.]
[R03BA08, ciclesonide, The metabolism of Ciclesonide can be decreased when combined with Doxazosin.]
[B01AC10, indobufen, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Indobufen.]
[M01AH03, valdecoxib, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Valdecoxib.]
[A03AX10, isometheptene, The therapeutic efficacy of Isometheptene can be decreased when used in combination with Doxazosin.]
[N02CC05, almotriptan, Almotriptan may decrease the antihypertensive activities of Doxazosin.]
[M01AH04, parecoxib, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Parecoxib.]
[J02AC02, itraconazole, The metabolism of Doxazosin can be decreased when combined with Itraconazole.]
[S01AD03, acyclovir, The risk or severity of adverse effects can be increased when Doxazosin is combined with Acyclovir.]
[N05BA10, ketazolam, The metabolism of Doxazosin can be decreased when combined with Ketazolam.]
[M01AA06, kebuzone, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Kebuzone.]
[L01EA01, imatinib, The serum concentration of Doxazosin can be increased when it is combined with Imatinib.]
[J02AC04, posaconazole, The metabolism of Doxazosin can be decreased when combined with Posaconazole.]
[A02BC05, esomeprazole, The metabolism of Doxazosin can be decreased when combined with Esomeprazole.]
[S01EE04, travoprost, Travoprost may increase the hypotensive activities of Doxazosin.]
[S01EE03, bimatoprost, Doxazosin may increase the hypotensive activities of Bimatoprost.]
[C08CA09, lacidipine, Doxazosin may increase the hypotensive activities of Lacidipine.]
[S01BA03, cortisone, The metabolism of Doxazosin can be increased when combined with Cortisone.]
[N07BC04, lofexidine, The therapeutic efficacy of Lofexidine can be decreased when used in combination with Doxazosin.]
[M01AB09, lonazolac, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Lonazolac.]
[M02AA31, loxoprofen, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Loxoprofen.]
[C09AA03, lisinopril, Doxazosin may increase the hypotensive activities of Lisinopril.]
[C08CA11, manidipine, The metabolism of Doxazosin can be decreased when combined with Manidipine.]
[A08AA09, mefenorex, Mefenorex may decrease the antihypertensive activities of Doxazosin.]
[C07AA14, mepindolol, Mepindolol may increase the orthostatic hypotensive activities of Doxazosin.]
[H02AB15, meprednisone, The metabolism of Doxazosin can be increased when combined with Meprednisone.]
[R06AD07, mequitazine, The metabolism of Doxazosin can be decreased when combined with Mequitazine.]
[C04AX01, cyclandelate, The risk or severity of hypotension can be increased when Doxazosin is combined with Cyclandelate.]
[R03CB02, methoxyphenamine, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Methoxyphenamine.]
[R06AE03, cyclizine, The metabolism of Doxazosin can be decreased when combined with Cyclizine.]
[C03DA04, eplerenone, Doxazosin may increase the hypotensive activities of Eplerenone.]
[N05AD03, metylperon, The metabolism of Doxazosin can be decreased when combined with Melperone.]
[C03AA07, cyclopenthiazide, The therapeutic efficacy of Doxazosin can be increased when used in combination with Cyclopenthiazide.]
[J01FA03, midecamycin, The metabolism of Doxazosin can be decreased when combined with Midecamycin.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be decreased when combined with Doxazosin.]
[N06AX07, minaprine, Minaprine may increase the hypotensive activities of Doxazosin.]
[S01XA18, cyclosporine, The metabolism of Doxazosin can be decreased when combined with Cyclosporine.]
[N06AG02, moclobemide, Moclobemide may increase the hypotensive activities of Doxazosin.]
[N06BA07, modafinil, The metabolism of Doxazosin can be decreased when combined with Modafinil.]
[C09AA13, moexipril, Doxazosin may increase the hypotensive activities of Moexipril.]
[C10AA07, rosuvastatin, The metabolism of Rosuvastatin can be decreased when combined with Doxazosin.]
[M02AA02, mofebutazone, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Mofebutazone.]
[M01AX22, morniflumate, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Morniflumate.]
[C03XA02, conivaptan, The metabolism of Doxazosin can be decreased when combined with Conivaptan.]
[C02AC05, moxonidine, The therapeutic efficacy of Moxonidine can be decreased when used in combination with Doxazosin.]
[L01BC01, cytarabine, The risk or severity of adverse effects can be increased when Doxazosin is combined with Cytarabine.]
[G04BE09, vardenafil, The risk or severity of hypotension can be increased when Vardenafil is combined with Doxazosin.]
[M01AH05, etoricoxib, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Etoricoxib.]
[G03XA01, danazol, The metabolism of Doxazosin can be decreased when combined with Danazol.]
[J04BA02, dapsone, The metabolism of Doxazosin can be decreased when combined with Dapsone.]
[L01DB02, daunorubicin, The metabolism of Doxazosin can be decreased when combined with Daunorubicin.]
[C02CC04, debrisoquin, Doxazosin may increase the hypotensive activities of Debrisoquine.]
[A04AD11, nabilone, The risk or severity of adverse effects can be increased when Nabilone is combined with Doxazosin.]
[M01AX01, nabumetone, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Nabumetone.]
[C07AB12, nebivolol, The therapeutic efficacy of Nebivolol can be decreased when used in combination with Doxazosin.]
[N06AX06, nefazodone, The metabolism of Doxazosin can be decreased when combined with Nefazodone.]
[C01DX16, nicorandil, Nicorandil may increase the hypotensive activities of Doxazosin.]
[L02BB02, nilutamide, The metabolism of Doxazosin can be decreased when combined with Nilutamide.]
[C01CA23, theodrenaline, Doxazosin may decrease the hypertensive activities of Theodrenaline.]
[C01CA05, norfenefrine, The therapeutic efficacy of Norfenefrine can be decreased when used in combination with Doxazosin.]
[N06AB10, escitalopram, The serum concentration of Doxazosin can be increased when it is combined with Escitalopram.]
[G04BD08, solifenacin, Solifenacin may decrease the antihypertensive activities of Doxazosin.]
[A07EC03, olsalazine, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Olsalazine.]
[N06AA01, desipramine, The metabolism of Doxazosin can be decreased when combined with Desipramine.]
[H01BA02, desmopressin, Desmopressin may decrease the antihypertensive activities of Doxazosin.]
[C09XA02, aliskiren, Doxazosin may increase the hypotensive activities of Aliskiren.]
[M01AE12, oxaprozin, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Oxaprozin.]
[N03AF02, oxcarbazepine, The metabolism of Doxazosin can be increased when combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The metabolism of Doxazosin can be increased when combined with Dexamethasone.]
[G04BD04, oxybutynin, The metabolism of Doxazosin can be decreased when combined with Oxybutynin.]
[A08AA04, dexfenfluramine, The metabolism of Doxazosin can be decreased when combined with Dexfenfluramine.]
[L04AB04, adalimumab, The metabolism of Doxazosin can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, The metabolism of Doxazosin can be decreased when combined with Gefitinib.]
[N06BA02, dextroamphetamine, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Amphetamine.]
[R05DA09, dextromethorphan, The metabolism of Doxazosin can be decreased when combined with Dextromethorphan.]
[N03AC01, paramethadione, The metabolism of Paramethadione can be decreased when combined with Doxazosin.]
[N06AB05, paroxetine, The metabolism of Doxazosin can be decreased when combined with Paroxetine.]
[B01AC04, clopidogrel, The metabolism of Clopidogrel can be decreased when combined with Doxazosin.]
[N05BA01, diazepam, The metabolism of Diazepam can be decreased when combined with Doxazosin.]
[V03AH01, diazoxide, Diazoxide may increase the hypotensive activities of Doxazosin.]
[N06AA08, dibenzepin, Dibenzepin may decrease the antihypertensive activities of Doxazosin.]
[S01EC02, dichlorphenamide, The risk or severity of adverse effects can be increased when Doxazosin is combined with Diclofenamide.]
[S01BC03, diclofenac, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Diclofenac.]
[J01CF01, dicloxacillin, The metabolism of Doxazosin can be increased when combined with Dicloxacillin.]
[C02DG01, pinacidil, Doxazosin may increase the hypotensive activities of Pinacidil.]
[A03AX04, pinaverium, The risk or severity of hypotension can be increased when Doxazosin is combined with Pinaverium.]
[N05AD05, pipamperone, The risk or severity of adverse effects can be increased when Doxazosin is combined with Pipamperone.]
[L01DC04, ixabepilone, The metabolism of Ixabepilone can be decreased when combined with Doxazosin.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Doxazosin.]
[R03CC07, pirbuterol, The therapeutic efficacy of Pirbuterol can be decreased when used in combination with Doxazosin.]
[A08AA03, diethylpropion, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Diethylpropion.]
[L02AA01, diethylstilbestrol, The metabolism of Doxazosin can be decreased when combined with Diethylstilbestrol.]
[C08CA03, isradipine, The risk or severity of hypotension can be increased when Doxazosin is combined with Isradipine.]
[D07XC04, diflucortolone, The metabolism of Doxazosin can be increased when combined with Difluocortolone.]
[N02BA11, diflunisal, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Diflunisal.]
[C01AA04, digitoxin, The metabolism of Digitoxin can be decreased when combined with Doxazosin.]
[C02DB01, dihydralazine, Doxazosin may increase the hypotensive activities of Dihydralazine.]
[C04AE04, dihydroergocristine, The metabolism of Dihydroergocristine can be decreased when combined with Doxazosin.]
[N02CA01, dihydroergotamine, Dihydroergotamine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Doxazosin.]
[N02AA03, hydromorphone, The metabolism of Doxazosin can be decreased when combined with Hydromorphone.]
[J05AE08, atazanavir, The metabolism of Doxazosin can be decreased when combined with Atazanavir.]
[B01AC21, treprostinil, Treprostinil may increase the hypotensive activities of Doxazosin.]
[C08DB01, diltiazem, The risk or severity of hypotension can be increased when Doxazosin is combined with Diltiazem.]
[R03CC08, procaterol, The therapeutic efficacy of Procaterol can be decreased when used in combination with Doxazosin.]
[M02AX03, dimethyl sulfoxide, The metabolism of Doxazosin can be decreased when combined with Dimethyl sulfoxide.]
[N02BB04, propyphenazone, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Propyphenazone.]
[M01AB14, proglumetacin, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Proglumetacin.]
[C05CA03, diosmin, The metabolism of Doxazosin can be decreased when combined with Diosmin.]
[R06AA02, diphenhydramine, The metabolism of Doxazosin can be decreased when combined with Diphenhydramine.]
[N05CD10, quazepam, The metabolism of Quazepam can be decreased when combined with Doxazosin.]
[C09AA06, quinapril, Doxazosin may increase the hypotensive activities of Quinapril.]
[B01AC07, dipyridamole, The risk or severity of hypotension can be increased when Dipyridamole is combined with Doxazosin.]
[N06BA11, dexmethylphenidate, Dexmethylphenidate may decrease the antihypertensive activities of Doxazosin.]
[N06AA23, quinupramine, Quinupramine may decrease the antihypertensive activities of Doxazosin.]
[A03FA02, cisapride, The metabolism of Doxazosin can be decreased when combined with Cisapride.]
[C09AA05, ramipril, Ramipril may increase the hypotensive activities of Doxazosin.]
[S01XA23, sirolimus, The metabolism of Sirolimus can be decreased when combined with Doxazosin.]
[N05AL04, remoxipride, The metabolism of Doxazosin can be decreased when combined with Remoxipride.]
[R03CC14, reproterol, The therapeutic efficacy of Reproterol can be decreased when used in combination with Doxazosin.]
[S02AA12, rifamycin SV, The metabolism of Doxazosin can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Doxazosin can be increased when combined with Rifapentine.]
[N05AX08, risperidone, Doxazosin may increase the hypotensive activities of Risperidone.]
[N01BB09, ropivacaine, The risk or severity of adverse effects can be increased when Ropivacaine is combined with Doxazosin.]
[L01EX01, sunitinib, The metabolism of Sunitinib can be decreased when combined with Doxazosin.]
[A04AD12, aprepitant, The metabolism of Doxazosin can be decreased when combined with Aprepitant.]
[C03XA01, tolvaptan, The metabolism of Tolvaptan can be decreased when combined with Doxazosin.]
[L01XG01, bortezomib, The metabolism of Bortezomib can be decreased when combined with Doxazosin.]
[J05AE07, fosamprenavir, The metabolism of Doxazosin can be decreased when combined with Fosamprenavir.]
[G04BE08, tadalafil, The risk or severity of hypotension can be increased when Tadalafil is combined with Doxazosin.]
[S01BC05, ketorolac, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Ketorolac.]
[C02KX02, ambrisentan, Doxazosin may increase the hypotensive activities of Ambrisentan.]
[C01EB18, ranolazine, The serum concentration of Doxazosin can be increased when it is combined with Ranolazine.]
[N02BA06, salsalate, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Salsalate.]
[R03AC12, salmeterol, The therapeutic efficacy of Salmeterol can be decreased when used in combination with Doxazosin.]
[C01CA07, dobutamine, The therapeutic efficacy of Dobutamine can be decreased when used in combination with Doxazosin.]
[A03FA03, domperidone, The metabolism of Domperidone can be decreased when combined with Doxazosin.]
[C01CA04, dopamine, The risk or severity of adverse effects can be increased when Doxazosin is combined with Dopamine.]
[N06AA16, dothiepin, The metabolism of Doxazosin can be decreased when combined with Dosulepin.]
[R07AB01, doxapram, Doxapram may decrease the antihypertensive activities of Doxazosin.]
[N06AA12, doxepin, Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Doxepin.]
[L01DB01, doxorubicin, The metabolism of Doxorubicin can be decreased when combined with Doxazosin.]
[N06AB06, sertraline, The metabolism of Sertraline can be decreased when combined with Doxazosin.]
[N01AB08, sevoflurane, Sevoflurane may decrease the antihypertensive activities of Doxazosin.]
[N05AD08, droperidol, Droperidol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Doxazosin.]
[C10AA01, simvastatin, The metabolism of Doxazosin can be decreased when combined with Simvastatin.]
[C09AA11, spirapril, Doxazosin may increase the hypotensive activities of Spirapril.]
[N02CC01, sumatriptan, Sumatriptan may decrease the antihypertensive activities of Doxazosin.]
[C07AB13, talinolol, Talinolol may increase the orthostatic hypotensive activities of Doxazosin.]
[H01AA01, corticotropin, The metabolism of Doxazosin can be increased when combined with Corticotropin.]
[M01AC02, tenoxicam, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Tenoxicam.]
[G04CA03, terazosin, Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Terazosin.]
[D01BA02, terbinafine, The metabolism of Doxazosin can be decreased when combined with Terbinafine.]
[G04BD05, terodiline, The risk or severity of hypotension can be increased when Doxazosin is combined with Terodiline.]
[C07AA16, tertatolol, Tertatolol may increase the orthostatic hypotensive activities of Doxazosin.]
[S01GA02, tetrahydrozoline, The therapeutic efficacy of Tetryzoline can be decreased when used in combination with Doxazosin.]
[N06AX14, tianeptine, The metabolism of Tianeptine can be decreased when combined with Doxazosin.]
[C09AA02, enalapril, Enalapril may increase the hypotensive activities of Doxazosin.]
[M01AG02, tolfenamic acid, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Tolfenamic acid.]
[N06AG03, toloxatone, Toloxatone may increase the hypotensive activities of Doxazosin.]
[N06BA09, atomoxetine, Atomoxetine may decrease the antihypertensive activities of Doxazosin.]
[N03AX11, topiramate, The metabolism of Doxazosin can be increased when combined with Topiramate.]
[C03CA04, torsemide, The metabolism of Doxazosin can be decreased when combined with Torasemide.]
[R01AA09, tramazoline, Tramazoline may decrease the antihypertensive activities of Doxazosin.]
[C09AA10, trandolapril, Trandolapril may increase the hypotensive activities of Doxazosin.]
[R03CC11, tulobuterol, The therapeutic efficacy of Tulobuterol can be decreased when used in combination with Doxazosin.]
[C02CA06, urapidil, Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Urapidil.]
[L01CA04, vinorelbine, The metabolism of Vinorelbine can be decreased when combined with Doxazosin.]
[S01FB02, ephedrine, The therapeutic efficacy of Ephedrine can be decreased when used in combination with Doxazosin.]
[S01GX10, epinastine, The metabolism of Doxazosin can be decreased when combined with Epinastine.]
[N06AX16, venlafaxine, The metabolism of Doxazosin can be decreased when combined with Venlafaxine.]
[C01CX07, xamoterol, The therapeutic efficacy of Xamoterol can be decreased when used in combination with Doxazosin.]
[S01GA03, xylometazoline, The therapeutic efficacy of Xylometazoline can be decreased when used in combination with Doxazosin.]
[C08CA12, mepirodipine, Doxazosin may increase the antihypertensive activities of Barnidipine.]
[S01EA01, epinephrine, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Doxazosin.]
[C09AA15, zofenopril, Doxazosin may increase the hypotensive activities of Zofenopril.]
[N05CF02, zolpidem, The metabolism of Doxazosin can be decreased when combined with Zolpidem.]
[M01AB04, zomepirac, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Zomepirac.]
[N03AX15, zonisamide, The risk or severity of hypotension can be increased when Doxazosin is combined with Zonisamide.]
[N05CF01, zopiclone, The metabolism of Zopiclone can be decreased when combined with Doxazosin.]
[C02AC02, guanfacine, The therapeutic efficacy of Guanfacine can be decreased when used in combination with Doxazosin.]
[B01AC11, iloprost, Iloprost may increase the hypotensive activities of Doxazosin.]
[G02AB03, ergonovine, The therapeutic efficacy of Ergometrine can be decreased when used in combination with Doxazosin.]
[C04AE01, ergoloid mesylates, USP, Ergoloid mesylate may decrease the antihypertensive activities of Doxazosin.]
[N02CA02, ergotamine, The metabolism of Doxazosin can be decreased when combined with Ergotamine.]
[N03AG01, valproic acid, The metabolism of Doxazosin can be decreased when combined with Valproic acid.]
[S01AA17, erythromycin, The metabolism of Doxazosin can be decreased when combined with Erythromycin.]
[A02BC02, pantoprazole, The metabolism of Doxazosin can be decreased when combined with Pantoprazole.]
[H05BX01, cinacalcet, The metabolism of Doxazosin can be decreased when combined with Cinacalcet.]
[G03CA03, estradiol, The metabolism of Estradiol can be decreased when combined with Doxazosin.]
[J04AK02, ethambutol, The metabolism of Doxazosin can be decreased when combined with Ethambutol.]
[R03BA05, fluticasone, The metabolism of Doxazosin can be increased when combined with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Doxazosin can be decreased when combined with Fluvastatin.]
[C01CA15, gepefrine, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Gepefrine.]
[L02AA03, ethinyl estradiol, The metabolism of Doxazosin can be decreased when combined with Ethinylestradiol.]
[V03AF05, amifostine, Doxazosin may increase the hypotensive activities of Amifostine.]
[N03AD01, ethosuximide, The risk or severity of hypotension can be increased when Doxazosin is combined with Ethosuximide.]
[M01AC06, meloxicam, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Meloxicam.]
[S01XA06, ethylmorphine, The metabolism of Ethylmorphine can be decreased when combined with Doxazosin.]
[C01CA01, etilefrine, The therapeutic efficacy of Etilefrine can be decreased when used in combination with Doxazosin.]
[N01AX07, etomidate, The therapeutic efficacy of Etomidate can be decreased when used in combination with Doxazosin.]
[L01CB01, etoposide, The metabolism of Etoposide can be decreased when combined with Doxazosin.]
[N05AE03, sertindole, The metabolism of Sertindole can be decreased when combined with Doxazosin.]
[L04AD02, tacrolimus, The metabolism of Tacrolimus can be decreased when combined with Doxazosin.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Doxazosin.]
[R06AX12, terfenadine, The metabolism of Doxazosin can be decreased when combined with Terfenadine.]
[N06AX12, bupropion, The metabolism of Doxazosin can be decreased when combined with Bupropion.]
[N06AB08, fluvoxamine, The metabolism of Doxazosin can be decreased when combined with Fluvoxamine.]
[C01BC08, encainide, The metabolism of Encainide can be decreased when combined with Doxazosin.]
[P02CA03, albendazole, The metabolism of Doxazosin can be decreased when combined with Albendazole.]
[C08CA02, felodipine, The risk or severity of hypotension can be increased when Doxazosin is combined with Felodipine.]
[C08EA01, fendiline, The risk or severity of hypotension can be increased when Doxazosin is combined with Fendiline.]
[N03AX26, fenfluramine, The metabolism of Doxazosin can be decreased when combined with Fenfluramine.]
[M01AE04, fenoprofen, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Fenoprofen.]
[R03CC04, fenoterol, The therapeutic efficacy of Fenoterol can be decreased when used in combination with Doxazosin.]
[N02AB03, fentanyl, Fentanyl may decrease the antihypertensive activities of Doxazosin.]
[R03CC02, albuterol, The therapeutic efficacy of Salbutamol can be decreased when used in combination with Doxazosin.]
[L01BB06, clofarabine, The risk or severity of adverse effects can be increased when Doxazosin is combined with Clofarabine.]
[N07AX03, cevimeline, The metabolism of Doxazosin can be decreased when combined with Cevimeline.]
[C01BC04, flecainide, The metabolism of Flecainide can be decreased when combined with Doxazosin.]
[N02BG04, floctafenine, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Floctafenine.]
[J01CF05, floxacillin, The metabolism of Doxazosin can be increased when combined with Flucloxacillin.]
[J02AC01, fluconazole, The metabolism of Doxazosin can be decreased when combined with Fluconazole.]
[N07CA03, flunarizine, The risk or severity of hypotension can be increased when Doxazosin is combined with Flunarizine.]
[N05CD03, flunitrazepam, The metabolism of Flunitrazepam can be decreased when combined with Doxazosin.]
[D07AC08, fluocinonide, The metabolism of Doxazosin can be increased when combined with Fluocinonide.]
[N06AA14, melitracen, Melitracen may decrease the antihypertensive activities of Doxazosin.]
[H02AB03, fluocortolone, The metabolism of Doxazosin can be increased when combined with Fluocortolone.]
[V03AZ01, ethanol, Ethanol may increase the hypotensive activities of Doxazosin.]
[L01BC09, floxuridine, The metabolism of Doxazosin can be decreased when combined with Floxuridine.]
[L01BC02, fluorouracil, The metabolism of Doxazosin can be decreased when combined with Fluorouracil.]
[N06AB03, fluoxetine, The serum concentration of Doxazosin can be increased when it is combined with Fluoxetine.]
[N05AF01, flupenthixol, Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Flupentixol.]
[N05AB02, fluphenazine, The metabolism of Doxazosin can be decreased when combined with Fluphenazine.]
[S01BC04, flurbiprofen, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Flurbiprofen.]
[N05AG01, fluspirilene, The risk or severity of hypotension can be increased when Doxazosin is combined with Fluspirilene.]
[N06BX17, adrafinil, The therapeutic efficacy of Adrafinil can be decreased when used in combination with Doxazosin.]
[G01AX06, furazolidone, Furazolidone may increase the hypotensive activities of Doxazosin.]
[J05AE10, darunavir, The metabolism of Doxazosin can be decreased when combined with Darunavir.]
[C03CA01, furosemide, Doxazosin may increase the hypotensive activities of Furosemide.]
[N06DA04, galantamine, The metabolism of Galantamine can be decreased when combined with Doxazosin.]
[C08DA02, gallopamil, The risk or severity of hypotension can be increased when Doxazosin is combined with Gallopamil.]
[S01AD09, ganciclovir, The risk or severity of adverse effects can be increased when Doxazosin is combined with Ganciclovir.]
[N03AA04, barbexaclone, Barbexaclone may increase the hypotensive activities of Doxazosin.]
[C10AB04, gemfibrozil, The metabolism of Doxazosin can be decreased when combined with Gemfibrozil.]
[L01EA02, dasatinib, The metabolism of Dasatinib can be decreased when combined with Doxazosin.]
[N04BC06, cabergoline, The metabolism of Cabergoline can be decreased when combined with Doxazosin.]
[J05AG04, etravirine, The metabolism of Doxazosin can be increased when combined with Etravirine.]
[N03AD03, methsuximide, The risk or severity of hypotension can be increased when Doxazosin is combined with Methsuximide.]
[N01AH02, alfentanil, Alfentanil may decrease the antihypertensive activities of Doxazosin.]
[L01EH01, lapatinib, The metabolism of Lapatinib can be decreased when combined with Doxazosin.]
[A10BB01, glyburide, The metabolism of Glyburide can be decreased when combined with Doxazosin.]
[A10BB09, gliclazide, The metabolism of Gliclazide can be decreased when combined with Doxazosin.]
[A10BB07, glipizide, The metabolism of Glipizide can be decreased when combined with Doxazosin.]
[N05CM18, dexmedetomidine, The therapeutic efficacy of Dexmedetomidine can be decreased when used in combination with Doxazosin.]
[C05AE01, nitroglycerin, Doxazosin may increase the hypotensive activities of Nitroglycerin.]
[C01BD04, dofetilide, The metabolism of Dofetilide can be decreased when combined with Doxazosin.]
[M01AG01, mefenamic acid, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Mefenamic acid.]
[R03BA09, fluticasone furoate, The metabolism of Doxazosin can be increased when combined with Fluticasone furoate.]
[L01EX02, sorafenib, The metabolism of Doxazosin can be decreased when combined with Sorafenib.]
[C07AB09, esmolol, Esmolol may increase the orthostatic hypotensive activities of Doxazosin.]
[B01AA12, fluindione, The metabolism of Fluindione can be decreased when combined with Doxazosin.]
[C09AA09, fosinopril, Fosinopril may increase the hypotensive activities of Doxazosin.]
[D01BA01, griseofulvin, The metabolism of Doxazosin can be increased when combined with Griseofulvin.]
[S01EX01, guanethidine, Doxazosin may increase the hypotensive activities of Guanethidine.]
[P01BX01, halofantrine, The metabolism of Doxazosin can be decreased when combined with Halofantrine.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Doxazosin.]
[N01AB01, halothane, Halothane may decrease the antihypertensive activities of Doxazosin.]
[N05AH04, quetiapine, Quetiapine may increase the hypotensive activities of Doxazosin.]
[L01CE02, irinotecan, The metabolism of Irinotecan can be decreased when combined with Doxazosin.]
[C09CA01, losartan, The metabolism of Doxazosin can be decreased when combined with Losartan.]
[G03DC01, allylestrenol, The metabolism of Allylestrenol can be decreased when combined with Doxazosin.]
[A07EC02, mesalamine, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Mesalazine.]
[N05CA16, hexobarbital, Hexobarbital may increase the hypotensive activities of Doxazosin.]
[R03CC05, hexoprenaline, The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Doxazosin.]
[J05AG01, nevirapine, The metabolism of Doxazosin can be decreased when combined with Nevirapine.]
[C08CA10, nilvadipine, The risk or severity of hypotension can be increased when Doxazosin is combined with Nilvadipine.]
[M02AA26, nimesulide, The risk or severity of hypotension can be increased when Doxazosin is combined with Nimesulide.]
[C09AA04, perindopril, Doxazosin may increase the hypotensive activities of Perindopril.]
[C02DB02, hydralazine, The metabolism of Doxazosin can be decreased when combined with Hydralazine.]
[C03AA03, hydrochlorothiazide, The therapeutic efficacy of Doxazosin can be increased when used in combination with Hydrochlorothiazide.]
[S02BA01, hydrocortisone, The metabolism of Doxazosin can be increased when combined with Hydrocortisone.]
[C03AA02, hydroflumethiazide, The therapeutic efficacy of Doxazosin can be increased when used in combination with Hydroflumethiazide.]
[G04BD06, propiverine, Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Propiverine.]
[P01BA02, hydroxychloroquine, The metabolism of Doxazosin can be decreased when combined with Hydroxychloroquine.]
[N05BB01, hydroxyzine, The metabolism of Doxazosin can be decreased when combined with Hydroxyzine.]
[J04AB04, rifabutin, The metabolism of Doxazosin can be increased when combined with Rifabutin.]
[C02AC06, rilmenidine, The therapeutic efficacy of Rilmenidine can be decreased when used in combination with Doxazosin.]
[R02AX02, ibuprofen, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Ibuprofen.]
[L01DB06, idarubicin, The metabolism of Idarubicin can be decreased when combined with Doxazosin.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be decreased when combined with Doxazosin.]
[N01AH03, sufentanil, Sufentanil may decrease the antihypertensive activities of Doxazosin.]
[N06AA02, imipramine, Imipramine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Doxazosin.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be decreased when combined with Doxazosin.]
[M03BX02, tizanidine, The therapeutic efficacy of Tizanidine can be decreased when used in combination with Doxazosin.]
[C03BA11, indapamide, The therapeutic efficacy of Indapamide can be increased when used in combination with Doxazosin.]
[S01BC01, indomethacin, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Indomethacin.]
[C02CA02, indoramin, Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Indoramin.]
[N06AX17, milnacipran, The metabolism of Doxazosin can be decreased when combined with Milnacipran.]
[N05CH02, ramelteon, The metabolism of Ramelteon can be decreased when combined with Doxazosin.]
[C10AA06, cerivastatin, The metabolism of Doxazosin can be increased when combined with Cerivastatin.]
[C07AA01, alprenolol, Alprenolol may increase the orthostatic hypotensive activities of Doxazosin.]
[V03AB01, ipecac, The metabolism of Ipecac can be decreased when combined with Doxazosin.]
[N06AA13, iprindole, Iprindole may decrease the antihypertensive activities of Doxazosin.]
[N06AF05, iproniazid, Iproniazid may increase the hypotensive activities of Doxazosin.]
[N06AF01, isocarboxazid, Isocarboxazid may increase the hypotensive activities of Doxazosin.]
[S01EC03, dorzolamide, Doxazosin may increase the hypotensive activities of Dorzolamide.]
[P01AX06, atovaquone, The metabolism of Doxazosin can be decreased when combined with Atovaquone.]
[R03CC06, isoetharine, The therapeutic efficacy of Isoetharine can be decreased when used in combination with Doxazosin.]
[C09AA16, imidapril, Doxazosin may increase the hypotensive activities of Imidapril.]
[N01AB06, isoflurane, Isoflurane may decrease the antihypertensive activities of Doxazosin.]
[N04BX02, entacapone, The metabolism of Doxazosin can be decreased when combined with Entacapone.]
[J04AC01, isoniazid, The metabolism of Doxazosin can be decreased when combined with Isoniazid.]
[R03CB01, isoproterenol, The therapeutic efficacy of Isoprenaline can be decreased when used in combination with Doxazosin.]
[C05AE02, isosorbide dinitrate, The risk or severity of adverse effects can be increased when Doxazosin is combined with Isosorbide dinitrate.]
[C04AA01, isoxsuprine, The therapeutic efficacy of Isoxsuprine can be decreased when used in combination with Doxazosin.]
[N06AX18, reboxetine, The metabolism of Doxazosin can be decreased when combined with Reboxetine.]
[L04AC07, tocilizumab, The metabolism of Doxazosin can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The metabolism of Ketamine can be decreased when combined with Doxazosin.]
[C02KD01, ketanserin, Doxazosin may increase the hypotensive activities of Ketanserin.]
[B01AC22, prasugrel, The metabolism of Prasugrel can be decreased when combined with Doxazosin.]
[J02AB02, ketoconazole, The metabolism of Doxazosin can be decreased when combined with Ketoconazole.]
[N05AH03, olanzapine, Olanzapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Doxazosin.]
[M02AA10, ketoprofen, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Ketoprofen.]
[V03AC03, deferasirox, The metabolism of Doxazosin can be increased when combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Doxazosin can be increased when combined with Abatacept.]
[C01CA22, arbutamine, The therapeutic efficacy of Arbutamine can be decreased when used in combination with Doxazosin.]
[N04BC09, rotigotine, The metabolism of Doxazosin can be decreased when combined with Rotigotine.]
[C07AG01, labetalol, Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Labetalol.]
[N04BB01, amantadine, The risk or severity of adverse effects can be increased when Doxazosin is combined with Amantadine.]
[C02AA05, deserpidine, Doxazosin may increase the hypotensive activities of Deserpidine.]
[N03AX18, lacosamide, The metabolism of Lacosamide can be decreased when combined with Doxazosin.]
[N04BA01, levodopa, The risk or severity of hypotension and orthostatic hypotension can be increased when Doxazosin is combined with Levodopa.]
[S02DA01, lidocaine, The metabolism of Doxazosin can be decreased when combined with Lidocaine.]
[C08EX01, lidoflazine, The risk or severity of hypotension can be increased when Doxazosin is combined with Lidoflazine.]
[N06BA13, armodafinil, The metabolism of Doxazosin can be decreased when combined with Armodafinil.]
[C03DB01, amiloride, The risk or severity of adverse effects can be increased when Doxazosin is combined with Amiloride.]
[N02CA07, lisuride, Lisuride may decrease the antihypertensive activities of Doxazosin.]
[N06AA07, lofepramine, Lofepramine may decrease the antihypertensive activities of Doxazosin.]
[A07DA03, loperamide, The risk or severity of hypotension can be increased when Doxazosin is combined with Loperamide.]
[C10AA02, lovastatin, The metabolism of Doxazosin can be decreased when combined with Lovastatin.]
[G03DC03, lynestrenol, The metabolism of Lynestrenol can be decreased when combined with Doxazosin.]
[L01EG01, temsirolimus, The metabolism of Temsirolimus can be decreased when combined with Doxazosin.]
[V04CC02, magnesium sulfate, The risk or severity of hypotension can be increased when Doxazosin is combined with Magnesium sulfate.]
[L01EA03, nilotinib, The metabolism of Doxazosin can be decreased when combined with Nilotinib.]
[V04CX04, mannitol, The risk or severity of adverse effects can be increased when Doxazosin is combined with Mannitol.]
[N06AA21, maprotiline, The metabolism of Maprotiline can be decreased when combined with Doxazosin.]
[C02BB01, mecamylamine, Doxazosin may increase the hypotensive activities of Mecamylamine.]
[R06AE05, meclizine, The metabolism of Meclizine can be decreased when combined with Doxazosin.]
[M02AA18, meclofenamic acid, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Meclofenamic acid.]
[N06DX01, memantine, The metabolism of Doxazosin can be decreased when combined with Memantine.]
[N02AB02, meperidine, The metabolism of Doxazosin can be decreased when combined with Meperidine.]
[C01CA11, mephentermine, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Mephentermine.]
[N03AB04, mephenytoin, The metabolism of Doxazosin can be decreased when combined with Mephenytoin.]
[N03AA01, mephobarbital, Methylphenobarbital may increase the hypotensive activities of Doxazosin.]
[L02BG01, aminoglutethimide, The metabolism of Doxazosin can be increased when combined with Aminoglutethimide.]
[N05AC03, mesoridazine, The metabolism of Mesoridazine can be decreased when combined with Doxazosin.]
[N05AX13, paliperidone, Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Paliperidone.]
[C01CA09, metaraminol, The therapeutic efficacy of Metaraminol can be decreased when used in combination with Doxazosin.]
[A04AA04, dolasetron, The metabolism of Dolasetron can be decreased when combined with Doxazosin.]
[H01CB03, lanreotide, The metabolism of Doxazosin can be decreased when combined with Lanreotide.]
[N07BC02, methadone, The metabolism of Doxazosin can be decreased when combined with Methadone.]
[N06BA03, methamphetamine, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Metamfetamine.]
[J05AF05, lamivudine, The risk or severity of adverse effects can be increased when Doxazosin is combined with Lamivudine.]
[S01EC05, methazolamide, The risk or severity of adverse effects can be increased when Doxazosin is combined with Methazolamide.]
[G02CB05, metergoline, Metergoline may decrease the antihypertensive activities of Doxazosin.]
[H03BB02, methimazole, The metabolism of Doxazosin can be decreased when combined with Methimazole.]
[N05CA15, methohexital, Methohexital may increase the hypotensive activities of Doxazosin.]
[N02BG08, ziconotide, The risk or severity of hypotension can be increased when Doxazosin is combined with Ziconotide.]
[L04AX03, methotrexate, The metabolism of Methotrexate can be decreased when combined with Doxazosin.]
[N05AA02, methotrimeprazine, Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Methotrimeprazine.]
[C01CA10, methoxamine, The therapeutic efficacy of Methoxamine can be decreased when used in combination with Doxazosin.]
[N02BG09, methoxyflurane, Methoxyflurane may decrease the antihypertensive activities of Doxazosin.]
[C03AA08, methyclothiazide, The therapeutic efficacy of Doxazosin can be increased when used in combination with Methyclothiazide.]
[C02AB01, methyldopa, The therapeutic efficacy of Methyldopa can be decreased when used in combination with Doxazosin.]
[V04CG05, methylene blue, Methylene blue may increase the hypotensive activities of Doxazosin.]
[G02AB01, methylergonovine, The metabolism of Doxazosin can be decreased when combined with Methylergometrine.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be decreased when combined with Doxazosin.]
[N06BA04, methylphenidate, Methylphenidate may decrease the antihypertensive activities of Doxazosin.]
[H02AB04, methylprednisolone, The metabolism of Doxazosin can be increased when combined with Methylprednisolone.]
[N03AF03, rufinamide, The metabolism of Doxazosin can be increased when combined with Rufinamide.]
[N02CA04, methysergide, The metabolism of Doxazosin can be decreased when combined with Methysergide.]
[A03FA01, metoclopramide, The metabolism of Doxazosin can be decreased when combined with Metoclopramide.]
[C03BA08, metolazone, Metolazone may increase the hypotensive activities of Doxazosin.]
[C07AB02, metoprolol, The metabolism of Doxazosin can be decreased when combined with Metoprolol.]
[P01AB01, metronidazole, The metabolism of Doxazosin can be decreased when combined with Metronidazole.]
[V04CD01, metyrapone, The metabolism of Doxazosin can be increased when combined with Metyrapone.]
[C01BB02, mexiletine, The metabolism of Doxazosin can be decreased when combined with Mexiletine.]
[N06AX03, mianserin, Mianserin may decrease the antihypertensive activities of Doxazosin.]
[S02AA13, miconazole, The metabolism of Doxazosin can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Aminophenazone.]
[N05CD08, midazolam, The metabolism of Doxazosin can be decreased when combined with Midazolam.]
[C01CA17, midodrine, The therapeutic efficacy of Midodrine can be decreased when used in combination with Doxazosin.]
[G03XB01, mifepristone, The metabolism of Doxazosin can be decreased when combined with Mifepristone.]
[C09CA03, valsartan, The metabolism of Doxazosin can be decreased when combined with Valsartan.]
[D11AX01, minoxidil, Minoxidil may increase the hypotensive activities of Doxazosin.]
[J01FA11, miocamycin, The metabolism of Doxazosin can be decreased when combined with Miocamycin.]
[L01XX23, mitotane, The metabolism of Doxazosin can be increased when combined with Mitotane.]
[N06BA12, lisdexamfetamine, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Lisdexamfetamine.]
[L03AC01, aldesleukin, The metabolism of Doxazosin can be decreased when combined with Aldesleukin.]
[C01DX12, molsidomine, Molsidomine may increase the hypotensive activities of Doxazosin.]
[C01BD01, amiodarone, The metabolism of Doxazosin can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, Amitriptyline may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Doxazosin.]
[N02AA01, morphine, The risk or severity of adverse effects can be increased when Morphine is combined with Doxazosin.]
[A04AA05, palonosetron, The metabolism of Doxazosin can be decreased when combined with Palonosetron.]
[L04AB05, certolizumab pegol, The metabolism of Doxazosin can be increased when combined with Certolizumab pegol.]
[L01EX03, pazopanib, The metabolism of Pazopanib can be decreased when combined with Doxazosin.]
[N05CA02, amobarbital, Amobarbital may increase the hypotensive activities of Doxazosin.]
[P01BA06, amodiaquine, The metabolism of Doxazosin can be decreased when combined with Amodiaquine.]
[G04CA04, silodosin, The risk or severity of orthostatic hypotension and dizziness can be increased when Doxazosin is combined with Silodosin.]
[G03XC01, raloxifene, The metabolism of Doxazosin can be decreased when combined with Raloxifene.]
[N06AA17, amoxapine, Amoxapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Doxazosin.]
[N03AB05, fosphenytoin, The metabolism of Doxazosin can be increased when combined with Fosphenytoin.]
[C07AA12, nadolol, Nadolol may increase the orthostatic hypotensive activities of Doxazosin.]
[N04BC04, ropinirole, The risk or severity of adverse effects can be increased when Ropinirole is combined with Doxazosin.]
[J01CF06, nafcillin, The metabolism of Doxazosin can be increased when combined with Nafcillin.]
[V03AB15, naloxone, The metabolism of Doxazosin can be decreased when combined with Naloxone.]
[L04AC03, anakinra, The metabolism of Doxazosin can be increased when combined with Anakinra.]
[S01GA01, naphazoline, The therapeutic efficacy of Naphazoline can be decreased when used in combination with Doxazosin.]
[N06BA01, amphetamine, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Amphetamine.]
[M02AA12, naproxen, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Naproxen.]
[A10BG01, troglitazone, The metabolism of Doxazosin can be decreased when combined with Troglitazone.]
[N06AX21, duloxetine, The risk or severity of orthostatic hypotension and syncope can be increased when Doxazosin is combined with Duloxetine.]
[N04BX01, tolcapone, The risk or severity of adverse effects can be increased when Tolcapone is combined with Doxazosin.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be decreased when combined with Doxazosin.]
[L02BG04, letrozole, The metabolism of Doxazosin can be decreased when combined with Letrozole.]
[N01AH06, remifentanil, Remifentanil may decrease the antihypertensive activities of Doxazosin.]
[C01CX08, levosimendan, The risk or severity of adverse effects can be increased when Doxazosin is combined with Levosimendan.]
[N05AX14, iloperidone, Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Iloperidone.]
[J02AA01, amphotericin B, The risk or severity of adverse effects can be increased when Doxazosin is combined with Amphotericin B.]
[N06AX23, desvenlafaxine, The metabolism of Doxazosin can be decreased when combined with Desvenlafaxine.]
[C09CA07, telmisartan, The metabolism of Doxazosin can be decreased when combined with Telmisartan.]
[C10AD02, niacin, The metabolism of Doxazosin can be decreased when combined with Niacin.]
[N06AF02, nialamide, Nialamide may increase the hypotensive activities of Doxazosin.]
[C08CA04, nicardipine, Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Nicardipine.]
[C04AE02, nicergoline, Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Nicergoline.]
[P02DA01, niclosamide, The metabolism of Niclosamide can be decreased when combined with Doxazosin.]
[C08CA05, nifedipine, The serum concentration of Doxazosin can be decreased when it is combined with Nifedipine.]
[M02AA17, niflumic acid, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Niflumic acid.]
[V03AB22, amyl nitrite, The risk or severity of adverse effects can be increased when Doxazosin is combined with Amyl Nitrite.]
[C08CA06, nimodipine, The risk or severity of hypotension can be increased when Doxazosin is combined with Nimodipine.]
[C08CA07, nisoldipine, The risk or severity of hypotension can be increased when Doxazosin is combined with Nisoldipine.]
[C08CA08, nitrendipine, The risk or severity of hypotension can be increased when Doxazosin is combined with Nitrendipine.]
[R07AX01, nitric oxide, The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Doxazosin.]
[N04BC05, pramipexole, The risk or severity of adverse effects can be increased when Doxazosin is combined with Pramipexole.]
[C02DD01, nitroprusside, Nitroprusside may increase the hypotensive activities of Doxazosin.]
[N01AX13, nitrous oxide, Nitrous oxide may decrease the antihypertensive activities of Doxazosin.]
[C01CA03, norepinephrine, The therapeutic efficacy of Norepinephrine can be decreased when used in combination with Doxazosin.]
[G03DC02, norethindrone, The metabolism of Norethisterone can be decreased when combined with Doxazosin.]
[C02KX01, bosentan, The metabolism of Doxazosin can be increased when combined with Bosentan.]
[N06AA10, nortriptyline, Nortriptyline may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Doxazosin.]
[R05DA07, noscapine, The metabolism of Doxazosin can be decreased when combined with Noscapine.]
[G02CA02, nylidrin, The therapeutic efficacy of Nylidrin can be decreased when used in combination with Doxazosin.]
[H01CB02, octreotide, The metabolism of Doxazosin can be decreased when combined with Octreotide.]
[J01FA05, oleandomycin, The metabolism of Doxazosin can be decreased when combined with Oleandomycin.]
[L04AC04, rilonacept, The metabolism of Doxazosin can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Doxazosin can be increased when combined with Omeprazole.]
[N06AA05, opipramol, Opipramol may decrease the antihypertensive activities of Doxazosin.]
[N02AA02, opium, The metabolism of Opium can be decreased when combined with Doxazosin.]
[R03CB03, metaproterenol, The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Doxazosin.]
[G04CA02, tamsulosin, Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Tamsulosin.]
[P02BA02, oxamniquine, The metabolism of Doxazosin can be decreased when combined with Oxamniquine.]
[A14AA08, oxandrolone, The metabolism of Doxazosin can be decreased when combined with Oxandrolone.]
[C07AA02, oxprenolol, Oxprenolol may increase the orthostatic hypotensive activities of Doxazosin.]
[N02AA05, oxycodone, The metabolism of Doxazosin can be decreased when combined with Oxycodone.]
[C01DX03, oxyfedrine, The therapeutic efficacy of Oxyfedrine can be decreased when used in combination with Doxazosin.]
[S01GA04, oxymetazoline, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Oxymetazoline.]
[N02AA11, oxymorphone, The metabolism of Oxymorphone can be decreased when combined with Doxazosin.]
[S01BC02, oxyphenbutazone, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Oxyphenbutazone.]
[N05AH05, asenapine, Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Asenapine.]
[M03AC01, pancuronium, The risk or severity of adverse effects can be increased when Doxazosin is combined with Pancuronium.]
[G04BE02, papaverine, The risk or severity of adverse effects can be increased when Doxazosin is combined with Papaverine.]
[H02AB05, paramethasone, The metabolism of Doxazosin can be increased when combined with Paramethasone.]
[C02KC01, pargyline, Pargyline may increase the hypotensive activities of Doxazosin.]
[G04BD11, fesoterodine, The metabolism of Fesoterodine can be decreased when combined with Doxazosin.]
[C07AA23, penbutolol, Penbutolol may increase the orthostatic hypotensive activities of Doxazosin.]
[N05AG03, penfluridol, The risk or severity of hypotension can be increased when Doxazosin is combined with Penfluridol.]
[N05CA01, pentobarbital, The metabolism of Doxazosin can be increased when combined with Pentobarbital.]
[C04AD03, pentoxifylline, Pentoxifylline may increase the hypotensive activities of Doxazosin.]
[N04BC02, pergolide, The therapeutic efficacy of Pergolide can be decreased when used in combination with Doxazosin.]
[C08EX02, perhexiline, The metabolism of Doxazosin can be decreased when combined with Perhexiline.]
[N05AB03, perphenazine, The metabolism of Doxazosin can be decreased when combined with Perphenazine.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Doxazosin.]
[N06AF03, phenelzine, Phenelzine may increase the hypotensive activities of Doxazosin.]
[A10BA01, phenformin, The risk or severity of adverse effects can be increased when Doxazosin is combined with Phenformin.]
[N03AA02, phenobarbital, The metabolism of Doxazosin can be increased when combined with Phenobarbital.]
[C04AX02, phenoxybenzamine, Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Phenoxybenzamine.]
[B01AA04, phenprocoumon, The metabolism of Phenprocoumon can be decreased when combined with Doxazosin.]
[A08AA01, phentermine, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Phentermine.]
[V03AB36, phentolamine, Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Phentolamine.]
[M02AA01, phenylbutazone, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Phenylbutazone.]
[S01GA05, phenylephrine, The therapeutic efficacy of Phenylephrine can be decreased when used in combination with Doxazosin.]
[A02BC06, dexlansoprazole, The metabolism of Doxazosin can be decreased when combined with Dexlansoprazole.]
[R01BA01, phenylpropanolamine, The therapeutic efficacy of Phenylpropanolamine can be decreased when used in combination with Doxazosin.]
[N03AB02, phenytoin, The metabolism of Doxazosin can be increased when combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Doxazosin can be increased when combined with Golimumab.]
[L02BB03, bicalutamide, The metabolism of Bicalutamide can be decreased when combined with Doxazosin.]
[C08CX01, mibefradil, The risk or severity of hypotension can be increased when Doxazosin is combined with Mibefradil.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Doxazosin.]
[C07AA03, pindolol, Pindolol may increase the orthostatic hypotensive activities of Doxazosin.]
[J05AE01, saquinavir, The metabolism of Doxazosin can be decreased when combined with Saquinavir.]
[P02CB01, piperazine, The metabolism of Piperazine can be decreased when combined with Doxazosin.]
[N05AC04, pipothiazine, The metabolism of Doxazosin can be decreased when combined with Pipotiazine.]
[C09CA02, eprosartan, Doxazosin may increase the hypotensive activities of Eprosartan.]
[S01BC06, piroxicam, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Piroxicam.]
[N02CX01, pizotyline, Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Pizotifen.]
[J05AG02, delavirdine, The metabolism of Doxazosin can be decreased when combined with Delavirdine.]
[C09CA04, irbesartan, The metabolism of Doxazosin can be decreased when combined with Irbesartan.]
[A10BG02, rosiglitazone, The metabolism of Doxazosin can be decreased when combined with Rosiglitazone.]
[A03AE01, alosetron, The metabolism of Alosetron can be decreased when combined with Doxazosin.]
[L04AC08, canakinumab, The metabolism of Doxazosin can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, The therapeutic efficacy of Doxazosin can be increased when used in combination with Polythiazide.]
[J05AE03, ritonavir, The metabolism of Doxazosin can be decreased when combined with Ritonavir.]
[C10AA08, pitavastatin, The metabolism of Pitavastatin can be decreased when combined with Doxazosin.]
[C07AB01, practolol, Practolol may increase the orthostatic hypotensive activities of Doxazosin.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be decreased when combined with Doxazosin.]
[C02CA01, prazosin, The risk or severity of hypotension can be increased when Prazosin is combined with Doxazosin.]
[S03BA02, prednisolone, The metabolism of Doxazosin can be increased when combined with Prednisolone.]
[C01DX02, prenylamine, The risk or severity of hypotension can be increased when Doxazosin is combined with Prenylamine.]
[P01BA03, primaquine, The metabolism of Doxazosin can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Doxazosin can be increased when combined with Primidone.]
[M04AB01, probenecid, The metabolism of Doxazosin can be increased when combined with Probenecid.]
[C01BA02, procainamide, The metabolism of Procainamide can be decreased when combined with Doxazosin.]
[S01HA05, procaine, Procaine may increase the hypotensive activities of Doxazosin.]
[L01XB01, procarbazine, Procarbazine may increase the hypotensive activities of Doxazosin.]
[C10AB05, fenofibrate, The metabolism of Fenofibrate can be decreased when combined with Doxazosin.]
[N05AB04, prochlorperazine, The metabolism of Doxazosin can be decreased when combined with Prochlorperazine.]
[G03DA04, progesterone, The metabolism of Doxazosin can be decreased when combined with Progesterone.]
[N05AA03, promazine, Promazine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Doxazosin.]
[R06AD02, promethazine, The metabolism of Doxazosin can be decreased when combined with Promethazine.]
[C01BC03, propafenone, The metabolism of Doxazosin can be decreased when combined with Propafenone.]
[N05AC01, periciazine, Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Periciazine.]
[N05CM06, propiomazine, Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Propiomazine.]
[L01XH02, romidepsin, The metabolism of Romidepsin can be decreased when combined with Doxazosin.]
[N01AX10, propofol, Propofol may decrease the antihypertensive activities of Doxazosin.]
[N02AC04, propoxyphene, The metabolism of Doxazosin can be decreased when combined with Dextropropoxyphene.]
[C07AA05, propranolol, Propranolol may increase the orthostatic hypotensive activities of Doxazosin.]
[N02CC04, rizatriptan, Rizatriptan may decrease the antihypertensive activities of Doxazosin.]
[B01AC09, epoprostenol, Epoprostenol may increase the hypotensive activities of Doxazosin.]
[R03DC03, montelukast, The metabolism of Doxazosin can be decreased when combined with Montelukast.]
[N06AA11, protriptyline, Protriptyline may decrease the antihypertensive activities of Doxazosin.]
[R01BA02, pseudoephedrine, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Pseudoephedrine.]
[N05AX12, aripiprazole, Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Aripiprazole.]
[R06AC01, pyrilamine, The metabolism of Doxazosin can be decreased when combined with Mepyramine.]
[C01BA01, quinidine, Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quinidine.]
[P01BC01, quinine, The metabolism of Doxazosin can be decreased when combined with Quinine.]
[A02BA02, ranitidine, The metabolism of Doxazosin can be decreased when combined with Ranitidine.]
[C02AA01, rescinnamine, Rescinnamine may decrease the antihypertensive activities of Doxazosin.]
[C02AA02, reserpine, Reserpine may increase the hypotensive activities of Doxazosin.]
[J04AB02, rifampin, The metabolism of Doxazosin can be increased when combined with Rifampicin.]
[R03AC05, rimiterol, The therapeutic efficacy of Rimiterol can be decreased when used in combination with Doxazosin.]
[G02CA01, ritodrine, The therapeutic efficacy of Ritodrine can be decreased when used in combination with Doxazosin.]
[J01FA06, roxithromycin, The metabolism of Doxazosin can be decreased when combined with Roxithromycin.]
[N02BA05, salicylamide, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Salicylamide.]
[A07EC01, sulfasalazine, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Sulfasalazine.]
[S01BC08, salicylic acid, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Salicylic acid.]
[N05CA06, secobarbital, Secobarbital may increase the hypotensive activities of Doxazosin.]
[N04BD01, selegiline, Selegiline may increase the hypotensive activities of Doxazosin.]
[L01FA03, obinutuzumab, Doxazosin may increase the hypotensive activities of Obinutuzumab.]
[H01CB01, somatostatin, The metabolism of Doxazosin can be decreased when combined with Somatostatin.]
[C07AA07, sotalol, The metabolism of Sotalol can be decreased when combined with Doxazosin.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be decreased when combined with Doxazosin.]
[C03DA01, spironolactone, The risk or severity of adverse effects can be increased when Spironolactone is combined with Doxazosin.]
[D07AB02, hydrocortisone butyrate, The metabolism of Doxazosin can be increased when combined with Hydrocortisone butyrate.]
[C01DA14, isosorbide mononitrate, The risk or severity of adverse effects can be increased when Doxazosin is combined with Isosorbide mononitrate.]
[H02CA04, levoketoconazole, The metabolism of Doxazosin can be decreased when combined with Levoketoconazole.]
[M01AE11, tiaprofenic acid, The therapeutic efficacy of Doxazosin can be decreased when used in combination with Tiaprofenic acid.]
[C03CC01, ethacrynic acid, The risk or severity of adverse effects can be increased when Doxazosin is combined with Etacrynic acid.]
